Multiple myositis-specific antibodies have been implicated in the diagnosis of dermatomyositis, of which Anti-Ro52 has been shown to be associated with a more severe form of concurrent interstitial lung disease [4]. The gene discussed is TRIM21; the disease is interstitial lung disease.